Literature DB >> 12110738

Risk of renal allograft loss from recurrent glomerulonephritis.

Esther M Briganti1, Graeme R Russ, John J McNeil, Robert C Atkins, Steven J Chadban.   

Abstract

BACKGROUND: Recurrent glomerulonephritis is a known cause of renal allograft loss; however, the incidence of this complication is poorly defined. We determined the incidence, timing, and relative importance of allograft loss due to the recurrence of glomerulonephritis.
METHODS: A total of 1505 patients with biopsy-proved glomerulonephritis received a primary renal transplant in Australia from 1988 through 1997. Recurrence was confirmed by renal biopsy. The Kaplan-Meier method was used to estimate the 10-year incidence of allograft failure due to recurrent glomerulonephritis, and this incidence was compared with the incidence of acute rejection, chronic rejection, and death with a functioning allograft. Characteristics of the recipients and donors were examined as potential predictors of recurrence.
RESULTS: Allograft loss due to the recurrence of glomerulonephritis occurred in 52 recipients, with a 10-year incidence of 8.4 percent (95 percent confidence interval, 5.9 to 12.0). The type of glomerulonephritis, the sex of the recipient, and the peak level of panel-reactive antibodies were independent predictors of the risk of recurrence. Recurrence was the third most frequent cause of allograft loss at 10 years, after chronic rejection and death with a functioning allograft. Despite the effect of recurrence, the overall 10-year incidence of allograft loss was similar among transplant recipients with biopsy-proved glomerulonephritis and among those with other causes of renal failure (45.4 percent [95 percent confidence interval, 40.9 to 50.2] vs. 45.8 percent [95 percent confidence interval, 42.3 to 49.3], P=0.09).
CONCLUSIONS: Recurrence is an important cause of allograft loss for those with renal failure due to glomerulonephritis. No risk factors for recurrence were identified that warrant altering the approach to transplantation. However, accurate estimates of risk can now be provided to potential recipients of renal allografts.

Entities:  

Mesh:

Year:  2002        PMID: 12110738     DOI: 10.1056/NEJMoa013036

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  95 in total

1.  Kidney Transplantation Outcomes across GN Subtypes in the United States.

Authors:  Michelle M O'Shaughnessy; Sai Liu; Maria E Montez-Rath; Colin R Lenihan; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

Review 2.  Chronic allograft nephropathy in paediatric renal transplantation.

Authors:  Stephen I Alexander; Jeffrey T Fletcher; Brian Nankivell
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

Review 3.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

4.  Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Authors:  Hans Orlent; Ron A Mathot; Eric F Van Bommel; Arnold G Vulto; Solko W Schalm; Johannes T Brouwer
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

5.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; David H Sachs; Megan Sykes; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

6.  Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

Authors:  Sami Alasfar; Dany Matar; Robert A Montgomery; Niraj Desai; Bonnie Lonze; Vikas Vujjini; Michelle M Estrella; John Manllo Dieck; Gebran Khneizer; Sanja Sever; Jochen Reiser; Nada Alachkar
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

7.  Monozygotic transplantation: concerns and opportunities.

Authors:  N Krishnan; P M Buchanan; N Dzebisashvili; H Xiao; M A Schnitzler; D C Brennan
Journal:  Am J Transplant       Date:  2008-09-19       Impact factor: 8.086

8.  Absence of MyD88 signaling induces donor-specific kidney allograft tolerance.

Authors:  Huiling Wu; Gerda A Noordmans; Maya R O'Brien; Jin Ma; Cathy Y Zhao; Geoff Y Zhang; Tony K T Kwan; Stephen I Alexander; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 10.121

9.  Transplantation: strength in numbers-predicting long-term transplant outcomes.

Authors:  William E Braun; Jesse D Schold
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

10.  Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.

Authors:  A Kattah; R Ayalon; L H Beck; S Sethi; D G Sandor; F G Cosio; M J Gandhi; E C Lorenz; D J Salant; F C Fervenza
Journal:  Am J Transplant       Date:  2015-03-12       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.